» Articles » PMID: 2233357

Use of WEB 2086 and WEB 2170 As Platelet-activating Factor Antagonists

Overview
Journal Methods Enzymol
Specialty Biochemistry
Date 1990 Jan 1
PMID 2233357
Citations 9
Authors
Affiliations
Soon will be listed here.
Citing Articles

Impact of targeting the platelet-activating factor and its receptor in cancer treatment.

Qaderi K, Shahmoradi A, Thyagarajan A, Sahu R Mil Med Res. 2025; 12(1):10.

PMID: 40033370 PMC: 11877967. DOI: 10.1186/s40779-025-00597-0.


The pathophysiological effects of Russell's viper () venom and its fractions in the isolated perfused rabbit kidney model: A potential role for platelet activating factor.

Chaiyabutr N, Chanhome L, Vasaruchapong T, Laoungbua P, Khow O, Rungsipipat A Toxicon X. 2020; 7:100046.

PMID: 32875291 PMC: 7452022. DOI: 10.1016/j.toxcx.2020.100046.


Forty Years Since the Structural Elucidation of Platelet-Activating Factor (PAF): Historical, Current, and Future Research Perspectives.

Lordan R, Tsoupras A, Zabetakis I, Demopoulos C Molecules. 2019; 24(23).

PMID: 31816871 PMC: 6930554. DOI: 10.3390/molecules24234414.


A Review on Platelet Activating Factor Inhibitors: Could a New Class of Potent Metal-Based Anti-Inflammatory Drugs Induce Anticancer Properties?.

Papakonstantinou V, Lagopati N, Tsilibary E, Demopoulos C, Philippopoulos A Bioinorg Chem Appl. 2017; 2017:6947034.

PMID: 28458618 PMC: 5387815. DOI: 10.1155/2017/6947034.


LysoPC and PAF Trigger Arachidonic Acid Release by Divergent Signaling Mechanisms in Monocytes.

Oestvang J, Anthonsen M, Johansen B J Lipids. 2011; 2011:532145.

PMID: 21912747 PMC: 3170782. DOI: 10.1155/2011/532145.